Florica Therapeutics, Inc.

San Francisco, CA

UEI
U481VWX5JH26
CAGE
8HFJ4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
899 Pine St #811, San Francisco, CA 94108, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Florica Therapeutics, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Sbir phase i: hypothalamus stem cell exosomes for treatment of covid-19 (covid-19) Grant · 2032822 Division of Industrial Innovation $275,678

Quick answers

What is Florica Therapeutics, Inc.'s UEI?

Florica Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is U481VWX5JH26.

What is Florica Therapeutics, Inc.'s CAGE code?

Florica Therapeutics, Inc.'s CAGE code is 8HFJ4.

What is Florica Therapeutics, Inc.'s primary NAICS code?

Florica Therapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Florica Therapeutics, Inc. located?

Florica Therapeutics, Inc.'s physical address in SAM.gov is 899 Pine St #811, San Francisco, CA 94108, USA.

Is Florica Therapeutics, Inc. registered in SAM.gov?

Yes. Florica Therapeutics, Inc.'s SAM.gov registration is active through March 18, 2027.

What is Florica Therapeutics, Inc.'s most recent federal award?

Florica Therapeutics, Inc.'s most recent federal grant award is Sbir phase i: hypothalamus stem cell exosomes for treatment of covid-19 (covid-19) (2032822), from Division of Industrial Innovation, on January 15, 2021.

On GovTribe

See Florica Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors